Literature DB >> 2312185

Interleukin-2 receptor expression in human mast cells and basophils.

N Maggiano1, F Colotta, F Castellino, R Ricci, S Valitutti, L M Larocca, P Musiani.   

Abstract

Surgical human thymus, upper respiratory tract, lung and small and large bowel specimens were analyzed for the presence of interleukin 2 receptor (IL2-R)-positive cells. Histochemical (toluidine) and immunologic (anti-IL2-R monoclonal antibody) staining procedures revealed a distinct anti-IL2-R positivity in most of metachromatically staining cells. These positive cells were observed not only in tissues showing strong inflammatory reaction and mast cell hyperplasia, as in Crohn's disease, but also in those not histologically affected by pathologic conditions. This finding suggested that human mast cells, like T blast cells, express the p55 chain of IL2-R on their surface. To see whether IL2-R was being actively synthesized, a cell preparation rich in peripheral blood basophils (PBB), which are cells closely related to mast cells, was obtained. Ultrastructural analysis of PBB after indirect immunogold procedure revealed that the vast majority expressed the IL2-R. Moreover, the presence of intracellular reaction products in the cytoplasm of most membrane-positive PBB was indicative of active antigen synthesis. Furthermore, Northern blot analysis evidenced specific IL2-R mRNA in PBB, while its expression was augmented several times when PBB were cultured in the presence of stimulated T cell supernatant.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2312185     DOI: 10.1159/000235082

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  4 in total

1.  Soluble interleukin-2 receptors and psoriasis.

Authors:  R Dummer; F G Dunkel
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Human eosinophils express functional interleukin 2 receptors.

Authors:  T H Rand; D S Silberstein; H Kornfeld; P F Weller
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

3.  The interleukin-2 receptor in lesions and serum of bullous pemphigoid.

Authors:  D Zillikens; A Ambach; M Schuessler; R Dummer; A A Hartmann; G Burg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

4.  Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.

Authors:  G Alì; L Boldrini; M Lucchi; A Picchi; M Dell'Omodarme; M C Prati; A Mussi; V Corsi; G Fontanini
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.